Antituberculosis Activity of Once-weekly Rifapentine-containing Regimens in Mice: Long-term Effectiveness with 6- and 8-Month Treatment Regimens
Authors:
- 1 May 2000
- journal article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 161 (5) , 1572-1577
Abstract
The effectiveness of various once-weekly 10 mg/kg rifapentine (P)- containing regimens for treatment of tuberculosis was assessed in mice infected intravenously with 4.3 × 106 colony-forming units (cfu) of Mycobacterium tuberculosis H37Rv, and treated 14 d later with various combinations of rifampin (R), P, isoniazid (H), pyrazinamide (Z), ethambutol (E), or streptomycin (S). Control mice treated daily with either 2-mo HRZ + 4-mo HR or 2-mo HRZ + 6-mo HE were rendered spleen and lung culture–negative at 6 mo and 8 mo, respectively. Treatment failure with emergence of R-resistant bacilli occurred in all mice given once-weekly monotherapy with P for 6 mo. Once-weekly PH treatment was successful at 6 mo when it was preceded by a 2-mo daily phase with HRZ. When the initial daily phase was reduced to 2 wk, once-weekly PH-containing treatment was successful, at 6 mo, only if it was supplemented with S during the initial daily and the once-weekly phases, and at 8 mo if it was supplemented with daily H during the once-weekly phase. Without these supplements, once-weekly treatment failed in some mice with selection of R-resistant or H-resistant mutants.Keywords
This publication has 11 references indexed in Scilit:
- Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazidThe Lancet, 1999
- In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1998
- Once-weekly Rifapentine-containing Regimens for Treatment of Tuberculosis in MiceAmerican Journal of Respiratory and Critical Care Medicine, 1998
- The American Lung Association Conference on Re-Establishing Control of Tuberculosis in the United StatesAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Preventive Therapy of Tuberculosis with Rifapentine in Immunocompetent and Nude MiceAmerican Journal of Respiratory and Critical Care Medicine, 1994
- Effectiveness of Rifampin, Rifabutin, and Rifapentine for Preventive Therapy of Tuberculosis in MiceAmerican Review of Respiratory Disease, 1993
- Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in miceAntimicrobial Agents and Chemotherapy, 1993
- Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in miceAntimicrobial Agents and Chemotherapy, 1992
- Experimental Short-course Preventive Therapy of Tuberculosis with Rifampin and PyrazinamideAmerican Review of Respiratory Disease, 1989
- Present Status of Chemotherapy for TuberculosisClinical Infectious Diseases, 1989